| Literature DB >> 25253697 |
Wenliang Zhang1, Emilio P Mottillo2, Jiawei Zhao1, Allison Gartung1, Garrett C VanHecke3, Jen-Fu Lee1, Krishna R Maddipati1, Haiyan Xu4, Young-Hoon Ahn3, Richard L Proia5, James G Granneman6, Menq-Jer Lee7.
Abstract
Adipocyte lipolysis can increase the production of inflammatory cytokines such as interleukin-6 (IL-6) that promote insulin resistance. However, the mechanisms that link lipolysis with inflammation remain elusive. Acute activation of β3-adrenergic receptors (ADRB3) triggers lipolysis and up-regulates production of IL-6 in adipocytes, and both of these effects are blocked by pharmacological inhibition of hormone-sensitive lipase. We report that stimulation of ADRB3 induces expression of sphingosine kinase 1 (SphK1) and increases sphingosine 1-phosphate production in adipocytes in a manner that also depends on hormone-sensitive lipase activity. Mechanistically, we found that adipose lipolysis-induced SphK1 up-regulation is mediated by the c-Jun N-terminal kinase (JNK)/activating protein-1 signaling pathway. Inhibition of SphK1 by sphingosine kinase inhibitor 2 diminished the ADRB3-induced IL-6 production both in vitro and in vivo. Induction of IL-6 by ADRB3 activation was suppressed by siRNA knockdown of Sphk1 in cultured adipocytes and was severely attenuated in Sphk1 null mice. Conversely, ectopic expression of SphK1 increased IL-6 expression in adipocytes. Collectively, these data demonstrate that SphK1 is a critical mediator in lipolysis-triggered inflammation in adipocytes.Entities:
Keywords: AP1 Transcription Factor (AP-1); Adipose Tissue; Beta 3 Adrenergic Receptor; Hormone-sensitive Lipase; Inflammation; Interleukin 6 (IL-6); Lipolysis; Sphingosine Kinase; c-Jun N-terminal Kinase (JNK)
Mesh:
Substances:
Year: 2014 PMID: 25253697 PMCID: PMC4231693 DOI: 10.1074/jbc.M114.601096
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.486